Prostate cancer is among the most commonly treated cancers in American men — and for the majority who are treated successfully, life after treatment brings a new challenge: erectile dysfunction. Whether the cause is radical prostatectomy, radiation therapy, or a combination of both, ED after prostate cancer treatment is not inevitable, and it is not permanent in many men. But recovery requires action, and it requires starting early.

As Director of Cancer Survivorship and Men's Health at Mary Bird Perkins Cancer Center, I work with men at every stage of this process — before treatment, immediately after, and years later when ED has gone unaddressed. The consistent finding in both clinical literature and my own practice is straightforward: men who begin structured penile rehabilitation early do significantly better than those who wait and hope for spontaneous recovery.

This article explains why ED develops after prostate cancer treatment, what the evidence says about rehabilitation, which therapies are used and when, and what realistic expectations look like.

50–90% ED Rate After Prostatectomy
40–60% ED Rate After Radiation
2 yrs Window for Best Nerve Recovery

Why Prostate Cancer Treatment Causes Erectile Dysfunction

To understand rehabilitation, it helps to understand the mechanism of injury. An erection depends on signals traveling through the cavernous nerves — two delicate nerve bundles that run along either side of the prostate on their way to the erectile tissue of the penis. Both radical prostatectomy and radiation therapy can damage these nerves, though through different mechanisms.

After Radical Prostatectomy

Even with nerve-sparing technique — which preserves the cavernous nerves rather than removing them — there is always a period of nerve injury called neuropraxia. The nerves are handled, stretched, or subject to local inflammatory changes, and their function is temporarily or partially lost. In the immediate post-surgical period, most men have no spontaneous erections at all.

The critical issue is what happens during this recovery window. When penile tissue goes without oxygenated blood — which normally flows during nighttime erections — smooth muscle cells within the corpora cavernosa begin to be replaced by fibrous tissue. This process, called corporeal fibrosis, is essentially scarring of erectile tissue. Once fibrosis develops significantly, even full nerve recovery may not restore adequate erectile function. The goal of penile rehabilitation is to prevent or minimize this fibrosis while the nerves heal.

After Radiation Therapy

Radiation-related ED develops more gradually. Rather than acute nerve injury, radiation causes progressive microvascular damage — the small blood vessels supplying erectile tissue are damaged over time, leading to reduced blood flow. ED after radiation often doesn't become apparent until 12 to 24 months post-treatment, and it tends to worsen progressively if untreated.

A Key Distinction

Post-prostatectomy ED is primarily a nerve injury problem in the short term and a fibrosis prevention problem over the first 1–2 years. Post-radiation ED is primarily a vascular problem that develops gradually. The rehabilitation approach overlaps significantly, but the timeline and expectations differ.

The Case for Starting Rehabilitation Early

The published evidence on early penile rehabilitation is consistent. Studies examining men who began rehabilitation within weeks of surgery — compared to those who waited for spontaneous recovery — show meaningfully better outcomes in erectile function at both one and two years post-operatively.

The mechanism is straightforward: by artificially producing erections or increasing penile blood flow during the period of nerve recovery, rehabilitation maintains oxygenation of erectile tissue, prevents smooth muscle atrophy, and reduces fibrosis. It doesn't accelerate nerve healing, but it preserves the tissue that will eventually respond once the nerves do recover.

"The nerve-sparing surgery preserves the hardware. Penile rehabilitation keeps the tissue healthy while we wait for the hardware to come back online. One without the other is a missed opportunity."

In practice, I discuss rehabilitation with every patient before their prostatectomy or radiation treatment begins. Setting expectations and establishing a plan in advance makes it far more likely that patients will follow through in the immediate post-operative period — when motivation is often low and recovery from surgery is the primary focus.

The Rehabilitation Toolkit: What We Use and When

Penile rehabilitation is not a single therapy. It is a structured, sequential approach that combines multiple treatments, adjusted over time based on the patient's recovery trajectory. Here is what the evidence supports:

Oral PDE5 Inhibitors — First-Line, Nightly

PDE5 inhibitors — sildenafil (Viagra), tadalafil (Cialis), or their generics — are the cornerstone of most rehabilitation protocols. Used nightly at a low dose rather than on-demand, they promote blood flow to penile tissue even in the absence of nerve-mediated erections. Studies support daily low-dose tadalafil (5mg) in particular for its sustained effect and tolerability.

The key point for patients to understand is that these medications are being used therapeutically, not recreationally. A nightly pill that produces no apparent erection is still doing meaningful work at the tissue level. Many men discontinue early because they don't see an immediate functional result — this is a mistake.

Vacuum Erection Device — Mechanical Rehabilitation

The vacuum erection device (VED) creates negative pressure around the penis, drawing blood into the corpora cavernosa and producing passive engorgement. Used daily without the constriction ring (which is used for intercourse), it functions as a penile stretching and oxygenation tool rather than a treatment for penetrative sex.

The VED is particularly valuable in the first weeks after surgery when oral medications may be less effective due to the degree of nerve disruption. I typically recommend daily VED use beginning 4 to 6 weeks post-operatively, once the surgical site has healed.

Intracavernosal Injections — When Oral Therapy Is Insufficient

For men who do not respond adequately to oral medications — which is common in the early post-operative period after nerve-sparing prostatectomy — intracavernosal injections (ICI) of alprostadil or Tri-Mix provide reliable erections directly, bypassing the nerve pathway entirely. This makes them particularly effective for rehabilitation when nerve recovery is incomplete.

Most men are understandably hesitant about injections at first. In practice, once patients are trained in the technique in-office and experience the result, the vast majority find the process manageable. The needle used is very fine, and discomfort is minimal with proper technique.

Low-Intensity Shockwave Therapy (LiSWT)

Low-intensity shockwave therapy is an emerging rehabilitation tool that uses acoustic pressure waves to stimulate angiogenesis — the growth of new blood vessels in erectile tissue. It is particularly relevant for radiation-related ED, where the underlying problem is vascular rather than neurogenic, and as an adjunct to other rehabilitation strategies post-prostatectomy.

In my practice I utilize the UroGold shockwave platform, which delivers focused low-energy acoustic waves using a published protocol. A course typically involves 6 to 12 in-office sessions of 15 to 20 minutes each. Published data suggest improvement in IIEF (International Index of Erectile Function) scores and enhanced response to PDE5 inhibitors following treatment.

A Practical Rehabilitation Timeline

Before Surgery or Radiation

Discuss baseline erectile function, set realistic expectations, and establish the rehabilitation plan. Men with better pre-treatment erectile function generally have better post-treatment outcomes. This is also the time to optimize cardiovascular health, weight, and any reversible contributing factors.

Weeks 1 – 6 Post-Prostatectomy

Focus is on surgical recovery. Once cleared, begin daily low-dose tadalafil (5mg) or sildenafil. VED can typically begin at 4–6 weeks. Expectations are managed: functional erections are not the goal at this stage — tissue health is.

Months 2 – 6

Intensify rehabilitation. If oral therapy alone is producing limited results, add ICI on a scheduled basis — typically 2 to 3 times per week. Continue VED. For radiation patients, begin monitoring for vascular ED onset and initiate therapy proactively if signs emerge.

Months 6 – 18

Continue multi-modal rehabilitation. Assess response and adjust. Consider LiSWT if vascular component is predominant. Some men begin to notice return of spontaneous erections in this window; others do not. Both trajectories can have good long-term outcomes with structured care.

18 – 24 Months

A meaningful assessment of nerve recovery is possible by this point. Men who have not recovered adequate erectile function despite consistent rehabilitation are appropriate candidates for penile implant evaluation. Waiting beyond two years without action allows fibrosis to progress, which can complicate implant surgery.

Beyond 2 Years

For men who have not recovered satisfactory function, the penile implant (inflatable penile prosthesis) remains the gold-standard solution — delivering reliable, on-demand erections with a satisfaction rate exceeding 95%. Many of my implant patients are post-prostatectomy men who are delighted by results they didn't believe were still possible.

Comparing the Main Rehabilitation Approaches

Therapy Best For When to Start Key Benefit
Daily PDE5i (tadalafil 5mg) All post-treatment patients 4–6 weeks post-op Tissue oxygenation, fibrosis prevention
Vacuum Erection Device Post-prostatectomy, early rehab 4–6 weeks post-op Passive engorgement, penile stretching
Intracavernosal Injections Poor oral medication response 2–3 months post-op Reliable erections bypassing nerve pathway
Shockwave Therapy (LiSWT) Vascular ED, radiation patients Anytime; 6+ months post-op ideal Angiogenesis, enhanced PDE5i response
Penile Implant (IPP) Persistent ED after 18–24 months After adequate rehab trial Permanent, on-demand solution; 95% satisfaction

What Are Realistic Expectations?

Honesty matters here. Not every man who undergoes nerve-sparing prostatectomy will recover spontaneous erectile function, even with ideal rehabilitation. Outcomes depend on age, pre-operative erectile function, degree of nerve preservation, and other comorbidities such as diabetes and cardiovascular disease.

Broadly speaking, younger men with strong baseline erectile function, bilateral nerve sparing, and no significant comorbidities have the best prognosis — with recovery rates of 60–80% in well-selected populations. Older men, those with partial nerve sparing, or those with significant vascular disease will have lower spontaneous recovery rates.

What I tell every patient is this: rehabilitation maximizes whatever potential for recovery exists. And if spontaneous recovery doesn't reach a satisfying level, there is still a very good answer — the penile implant — that produces reliable results regardless of nerve status.

A Note on Timing the Implant Decision

Men sometimes delay the implant conversation because it feels like giving up. In my experience, the men who frame it that way often wait too long. The implant is not giving up — it is choosing a definitive, proven solution after a good-faith effort at recovery. And from a surgical standpoint, earlier is better: progressive fibrosis makes the surgery technically more demanding and may affect the functional result.

The Role of a Cancer Survivorship Specialist

Oncologists and urologic surgeons who perform prostatectomies are experts in cancer treatment. Post-treatment sexual health is a separate subspecialty, and many men fall through the gap between their cancer care and their quality-of-life care. A cancer survivorship specialist bridges that gap — providing structured rehabilitation, monitoring recovery, adjusting treatment over time, and making the implant referral at the right moment when indicated.

My practice at Mary Bird Perkins Cancer Center is built around exactly this model. Men are referred to me by their oncologists and surgeons to manage the sexual health consequences of treatment — both immediately after treatment and years later when ED has gone unaddressed. It is never too late to start, though earlier is consistently better.

You Don't Have to Navigate This Alone.

Whether you're about to begin prostate cancer treatment, recently completed it, or are years out and dealing with untreated ED — a consultation is the right starting point. Everything is confidential.

Request a Consultation (504) 584-6990
M

Matthew J. Mutter, MD

Director, Cancer Survivorship & Men's Health · AMS 700 Center of Excellence

Dr. Mutter is an Associate Professor of Clinical Urology at LSU Health Sciences Center and Director of Cancer Survivorship and Men's Health at Mary Bird Perkins Cancer Center in Metairie, Louisiana. He is a national leader in prosthetic urology and male sexual health following cancer treatment, serving as Treasurer of the Society of Urogenital Prosthetic Surgeons (SUPS) and Surgical Committee Member of the Sexual Medicine Society of North America (SMSNA). He has given Louisiana legislative testimony on HB 508, which created health policy protections for male cancer survivors in Louisiana.

Medical Disclaimer This article is intended for educational purposes only and does not constitute medical advice. The information provided is not a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition or treatment decision. Individual outcomes vary. AMS 700™ is a registered trademark of Boston Scientific Corporation. UroGold™ is a registered trademark of its respective manufacturer.